Sat, Apr 19, 2014, 9:11 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • wesleydoctor wesleydoctor Nov 19, 2012 5:31 PM Flag

    Looks Like Early Approval Coming. READ

    Seeking Alpha 11/19
    The company has the backing of most of the organizations and parents for the early approval of the drug. Based on the medical need in this area and the social pressure, FDA may want to speed up the process of bringing the drug in the market.
    Sarepta has a wonderful drug in its pipeline, which can dominate the market for years. Unlike many other drugs, Eteplirsen has support from the public who want this drug to be in the market. It has shown phenomenal results and may force the FDA to approve the drug without phase III trials. Regardless of early approval, the stock will continue to move up in the short and medium term. However, if the early approval is granted - the stock will move up rapidly. In addition, it is extremely unlikely that the company will face competition any time soon. I remain particularly optimistic and confident that Sarepta will provide massive returns to investors.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
24.40+0.17(+0.70%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.